Nanoencapsulation of DMSA monoester for better therapeutic efficacy of the chelating agent against arsenic toxicity.
about
Nano drug delivery systems: a new paradigm for treating metal toxicity.Biological and environmental hazards associated with exposure to chemical warfare agents: arsenicals.In Vitro and In Vivo Evaluation of Lactobacillus delbrueckii subsp. bulgaricus KLDS1.0207 for the Alleviative Effect on Lead ToxicityComparative Assessment of the Bioremedial Potentials of Potato Resistant Starch-Based Microencapsulated and Non-encapsulated Lactobacillus plantarum to Alleviate the Effects of Chronic Lead Toxicity.
P2860
Nanoencapsulation of DMSA monoester for better therapeutic efficacy of the chelating agent against arsenic toxicity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Nanoencapsulation of DMSA mono ...... gent against arsenic toxicity.
@en
Nanoencapsulation of DMSA mono ...... gent against arsenic toxicity.
@nl
type
label
Nanoencapsulation of DMSA mono ...... gent against arsenic toxicity.
@en
Nanoencapsulation of DMSA mono ...... gent against arsenic toxicity.
@nl
prefLabel
Nanoencapsulation of DMSA mono ...... gent against arsenic toxicity.
@en
Nanoencapsulation of DMSA mono ...... gent against arsenic toxicity.
@nl
P2093
P2860
P356
P1433
P1476
Nanoencapsulation of DMSA mono ...... agent against arsenic toxicity
@en
P2093
Abhishek Yadav
Anil Kumar Babbar
Anil Kumar Mishra
Mahabir Parshad Kaushik
Mohammed Samim
Pramod Kushwaha
Rashi Mathur
Uma Pathak
Vinay Lomash
P2860
P304
P356
10.2217/NNM.13.17
P577
2014-04-01T00:00:00Z